Lessons Learned From COVID-19
The COVID-19 response illustrates steps officials should take to ensure the effectiveness of vaccine mandates.
A Win for the Federal Government’s Contracting Power
A recent court decision supports using procurement authority to address climate change and other policy issues.
Overturning Chevron Will Not Transform Congress
Claims about the consequences of remaking Chevron deference require empirical backing.
Is AI-Facilitated Gender-Based Violence the Next Pandemic?
The rise of deep fakes and other AI-generated misinformation presents a direct threat to women’s freedom.
The Case for Plural Business Purposes
Businesses should embrace corporate purposes beyond profit maximization.
SCOTUS Must Not Look Away as Pregnant Patients Suffer
The Supreme Court must maintain pregnant people’s right to receive emergency medical care—including abortion.
A New Era of Psychedelic Medicine in Australia
Australia implements a new framework for regulating the medicinal use of psychedelic substances such as MDMA and psilocybin.
It Is High Time the U.K. Changes Psychedelics Laws
The government should lower regulatory hurdles impeding psilocybin assisted psychotherapy research.
Why We Need To Talk About Psychedelic Dispensaries
Dispensaries could fill the regulatory void for psychedelics and promote public health.
Are Psychedelics Safe Enough for Recreational Use?
Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.
A Roadmap to Reimbursement for Psychedelics
Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.
Branching Regulatory Paths and Dead Ends in Psychedelics
The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.